Good news for patients who are sick of overpaying for Yaz and Climara. Instead of using your hard-earned money to generate rebates for your PBM and health plan, you can now get big savings from Mark Cuban Cost Plus Drug Company. npr.org/sections/healt… Sydney Lupkin Mark Cuban Alex Oshmyansky, MD, PhD

Our mission to end drug shortages just took a giant leap forward today – we are now providing Community Health Systems with affordable, lifesaving medications straight from our Dallas, Texas manufacturing facility! 📰 Read about it here: businesswire.com/news/home/2024… Together we are

Extremely excited about our partnership with CHS! Looking forward to our partnership to end drug shortages and bring down costs for health systems.

Neat Becker's Hospital Review story about how Community Health Systems became the first #hospital customer of Mark Cuban Mark Cuban Cost Plus Drug Company drugch.nl/43mp3T5

Our Administration is working to bring transparency to prescription drug middlemen – so they pass health care savings on to consumers instead of padding their own pockets. Watch as Mark Cuban and Dr. Alex Oshmyansky explain:

Great and highly informative talk by Ruchika Talwar on how to approach patients when they ask “Doc, how much will this drug cost me?” ✅Amazon pharmacy ✅GoodRx ✅Mark Cuban Cost Plus ✅Medicare Part D Southeastern Section

Excited to speaking on a panel at this conference on how we are using AI at Mark Cuban Cost Plus Drug Company to improve our manufacturing processes!

Do you remember when you joined X? I do! #MyXAnniversary

We are just getting started !

Thanks TIME ! Proud to be working with the amazing team at Mark Cuban Cost Plus Drug Company to help get rid of drug pricing scams.

Here's an #asco24 session on cancer drug shortages that you may want to get on your calendar - June 3rd 9:45 am. Great panel: @asco The Brookings Institution U.S. FDA Civica Rx Association for Accessible Medicines Mark Cuban Cost Plus Drug Company Marta Wosinska Alex Oshmyansky, MD, PhD Dr. Robert M. Califf Allan Coukell

Much of the problem with domestic drug costs are from intermediaries, explained Alex Oshmyansky, MD, PhD of Mark Cuban Cost Plus Drug Company , imatinib can be sold at $30/month, not $3000, despite sourcing the drugs for higher than do #pbm

Great session on Solving Decades of Drug Shortages in Oncology: What, Who, and When? With FDA Commissioner Alex Oshmyansky, MD, PhD Allan Coukell Marta Wosinska AAM Association for Accessible Medicines The Brookings Institution Dr. Robert M. Califf U.S. FDA Civica Rx Mark Cuban Cost Plus Drug Company @asco #asco24 Will be available to all (around the paywall) soon!

The Mark Cuban Mark Cuban effect in #CML …. Mind blowing 🤯 Talk about using your money and influence to do good in this world. #leusm #hemepath #endcancer Slide by Hagop Kantarjian,MD at MD Education

Proud of our supply chain team for working with the U.S. FDA to get this critical drug shortage medication into the country at an affordable cost!

The PBM Smackening is happening ! news.bloomberglaw.com/daily-labor-re…

Where others see an impossible problem, Mark Cuban Cost Plus Drug Company CEO Alex Oshmyansky, MD, PhD sees an opportunity to expose predatory health insurance practices and make healthcare a right, not a luxury. Watch: youtube.com/watch?v=klWfOC… #RapidResponse #Healthcare #CostPlusDrugs

The 2025 Anti-Monopoly Summit is almost here! Join us September 15th and 16th for discussions with lawmakers, business owners, journalists and more — including Mark Cuban Cost Plus Drug Company CEO Alex Oshmyansky, MD, PhD in conversation with David Dayen of The American Prospect.

When he isn’t disrupting the pharmaceutical industry, Dr. Alex Oshmyansky spends time leaning into turns at the racetrack on his motorcycle. l8r.it/9oLh

With our transparent pricing, more people can access the medications they need. Get started at costplusdrugs.com.